Aamaxan Transport Group, Inc.
Aamaxan Transport Group, Inc. (AAXT) Stock Competitors & Peer Comparison
See (AAXT) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Specialties Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| AAXT | $0.00 | -0.00% | 1.6K | N/A | $0.46 | N/A |
| BMXXY | $12.11 | +0.00% | 14.3B | 31.05 | $0.39 | +0.81% |
| EBOSY | $37.69 | +15.97% | 1.4B | 18.18 | $1.46 | +8.63% |
| AVNBF | $24.70 | +0.00% | 724M | 72.65 | $0.34 | +0.99% |
| EBRCZ | $0.48 | -0.73% | 355.3M | -3.97 | -$0.12 | N/A |
| XVIPY | $6.54 | +0.00% | 206M | N/A | N/A | N/A |
| TRXDW | $0.15 | -11.76% | 40.1M | N/A | N/A | N/A |
| ACIXF | $0.03 | +14.62% | 32.6M | -2.90 | -$0.01 | N/A |
| NVNBW | $0.01 | +0.00% | 141.5K | -0.00 | -$1.95 | N/A |
| GWPC | $0.00 | +0.00% | 52K | -0.01 | -$0.01 | N/A |
Stock Comparison
AAXT vs BMXXY Comparison April 2026
AAXT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AAXT stands at 1.6K. In comparison, BMXXY has a market cap of 14.3B. Regarding current trading prices, AAXT is priced at $0.00, while BMXXY trades at $12.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AAXT currently has a P/E ratio of N/A, whereas BMXXY's P/E ratio is 31.05. In terms of profitability, AAXT's ROE is +0.54%, compared to BMXXY's ROE of +0.10%. Regarding short-term risk, AAXT and BMXXY have similar daily volatility (0.00).Check BMXXY's competition here
AAXT vs EBOSY Comparison April 2026
AAXT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AAXT stands at 1.6K. In comparison, EBOSY has a market cap of 1.4B. Regarding current trading prices, AAXT is priced at $0.00, while EBOSY trades at $37.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AAXT currently has a P/E ratio of N/A, whereas EBOSY's P/E ratio is 18.18. In terms of profitability, AAXT's ROE is +0.54%, compared to EBOSY's ROE of +0.06%. Regarding short-term risk, AAXT and EBOSY have similar daily volatility (0.00).Check EBOSY's competition here
AAXT vs AVNBF Comparison April 2026
AAXT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AAXT stands at 1.6K. In comparison, AVNBF has a market cap of 724M. Regarding current trading prices, AAXT is priced at $0.00, while AVNBF trades at $24.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AAXT currently has a P/E ratio of N/A, whereas AVNBF's P/E ratio is 72.65. In terms of profitability, AAXT's ROE is +0.54%, compared to AVNBF's ROE of +0.05%. Regarding short-term risk, AAXT and AVNBF have similar daily volatility (0.00).Check AVNBF's competition here
AAXT vs EBRCZ Comparison April 2026
AAXT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AAXT stands at 1.6K. In comparison, EBRCZ has a market cap of 355.3M. Regarding current trading prices, AAXT is priced at $0.00, while EBRCZ trades at $0.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AAXT currently has a P/E ratio of N/A, whereas EBRCZ's P/E ratio is -3.97. In terms of profitability, AAXT's ROE is +0.54%, compared to EBRCZ's ROE of -329.75%. Regarding short-term risk, AAXT and EBRCZ have similar daily volatility (0.00).Check EBRCZ's competition here
AAXT vs XVIPY Comparison April 2026
AAXT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AAXT stands at 1.6K. In comparison, XVIPY has a market cap of 206M. Regarding current trading prices, AAXT is priced at $0.00, while XVIPY trades at $6.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AAXT currently has a P/E ratio of N/A, whereas XVIPY's P/E ratio is N/A. In terms of profitability, AAXT's ROE is +0.54%, compared to XVIPY's ROE of +0.05%. Regarding short-term risk, AAXT and XVIPY have similar daily volatility (0.00).Check XVIPY's competition here
AAXT vs TRXDW Comparison April 2026
AAXT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AAXT stands at 1.6K. In comparison, TRXDW has a market cap of 40.1M. Regarding current trading prices, AAXT is priced at $0.00, while TRXDW trades at $0.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AAXT currently has a P/E ratio of N/A, whereas TRXDW's P/E ratio is N/A. In terms of profitability, AAXT's ROE is +0.54%, compared to TRXDW's ROE of -1.18%. Regarding short-term risk, AAXT and TRXDW have similar daily volatility (0.00).Check TRXDW's competition here
AAXT vs ACIXF Comparison April 2026
AAXT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AAXT stands at 1.6K. In comparison, ACIXF has a market cap of 32.6M. Regarding current trading prices, AAXT is priced at $0.00, while ACIXF trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AAXT currently has a P/E ratio of N/A, whereas ACIXF's P/E ratio is -2.90. In terms of profitability, AAXT's ROE is +0.54%, compared to ACIXF's ROE of -1.04%. Regarding short-term risk, AAXT and ACIXF have similar daily volatility (0.00).Check ACIXF's competition here
AAXT vs NVNBW Comparison April 2026
AAXT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AAXT stands at 1.6K. In comparison, NVNBW has a market cap of 141.5K. Regarding current trading prices, AAXT is priced at $0.00, while NVNBW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AAXT currently has a P/E ratio of N/A, whereas NVNBW's P/E ratio is -0.00. In terms of profitability, AAXT's ROE is +0.54%, compared to NVNBW's ROE of -0.61%. Regarding short-term risk, AAXT is less volatile compared to NVNBW. This indicates potentially lower risk in terms of short-term price fluctuations for AAXT.Check NVNBW's competition here
AAXT vs GWPC Comparison April 2026
AAXT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AAXT stands at 1.6K. In comparison, GWPC has a market cap of 52K. Regarding current trading prices, AAXT is priced at $0.00, while GWPC trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AAXT currently has a P/E ratio of N/A, whereas GWPC's P/E ratio is -0.01. In terms of profitability, AAXT's ROE is +0.54%, compared to GWPC's ROE of N/A. Regarding short-term risk, AAXT and GWPC have similar daily volatility (0.00).Check GWPC's competition here
AAXT vs SXHHF Comparison April 2026
AAXT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AAXT stands at 1.6K. In comparison, SXHHF has a market cap of 38.1K. Regarding current trading prices, AAXT is priced at $0.00, while SXHHF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AAXT currently has a P/E ratio of N/A, whereas SXHHF's P/E ratio is -0.01. In terms of profitability, AAXT's ROE is +0.54%, compared to SXHHF's ROE of +1.13%. Regarding short-term risk, AAXT is less volatile compared to SXHHF. This indicates potentially lower risk in terms of short-term price fluctuations for AAXT.Check SXHHF's competition here
AAXT vs DGCRF Comparison April 2026
AAXT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AAXT stands at 1.6K. In comparison, DGCRF has a market cap of 21.5K. Regarding current trading prices, AAXT is priced at $0.00, while DGCRF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AAXT currently has a P/E ratio of N/A, whereas DGCRF's P/E ratio is 0.00. In terms of profitability, AAXT's ROE is +0.54%, compared to DGCRF's ROE of -1.11%. Regarding short-term risk, AAXT is less volatile compared to DGCRF. This indicates potentially lower risk in terms of short-term price fluctuations for AAXT.Check DGCRF's competition here
AAXT vs KKUR Comparison April 2026
AAXT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AAXT stands at 1.6K. In comparison, KKUR has a market cap of 8.2K. Regarding current trading prices, AAXT is priced at $0.00, while KKUR trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AAXT currently has a P/E ratio of N/A, whereas KKUR's P/E ratio is N/A. In terms of profitability, AAXT's ROE is +0.54%, compared to KKUR's ROE of N/A. Regarding short-term risk, AAXT is less volatile compared to KKUR. This indicates potentially lower risk in terms of short-term price fluctuations for AAXT.Check KKUR's competition here
AAXT vs SCIE Comparison April 2026
AAXT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AAXT stands at 1.6K. In comparison, SCIE has a market cap of 4.9K. Regarding current trading prices, AAXT is priced at $0.00, while SCIE trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AAXT currently has a P/E ratio of N/A, whereas SCIE's P/E ratio is -0.00. In terms of profitability, AAXT's ROE is +0.54%, compared to SCIE's ROE of +0.51%. Regarding short-term risk, AAXT and SCIE have similar daily volatility (0.00).Check SCIE's competition here
AAXT vs OMRX Comparison April 2026
AAXT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AAXT stands at 1.6K. In comparison, OMRX has a market cap of 4.7K. Regarding current trading prices, AAXT is priced at $0.00, while OMRX trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AAXT currently has a P/E ratio of N/A, whereas OMRX's P/E ratio is N/A. In terms of profitability, AAXT's ROE is +0.54%, compared to OMRX's ROE of -0.15%. Regarding short-term risk, AAXT and OMRX have similar daily volatility (0.00).Check OMRX's competition here
AAXT vs IBXG Comparison April 2026
AAXT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AAXT stands at 1.6K. In comparison, IBXG has a market cap of 2K. Regarding current trading prices, AAXT is priced at $0.00, while IBXG trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AAXT currently has a P/E ratio of N/A, whereas IBXG's P/E ratio is N/A. In terms of profitability, AAXT's ROE is +0.54%, compared to IBXG's ROE of N/A. Regarding short-term risk, AAXT and IBXG have similar daily volatility (0.00).Check IBXG's competition here
AAXT vs DMSI Comparison April 2026
AAXT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AAXT stands at 1.6K. In comparison, DMSI has a market cap of 1.9K. Regarding current trading prices, AAXT is priced at $0.00, while DMSI trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AAXT currently has a P/E ratio of N/A, whereas DMSI's P/E ratio is N/A. In terms of profitability, AAXT's ROE is +0.54%, compared to DMSI's ROE of -0.32%. Regarding short-term risk, AAXT and DMSI have similar daily volatility (0.00).Check DMSI's competition here
AAXT vs XCRP Comparison April 2026
AAXT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AAXT stands at 1.6K. In comparison, XCRP has a market cap of 1.5K. Regarding current trading prices, AAXT is priced at $0.00, while XCRP trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AAXT currently has a P/E ratio of N/A, whereas XCRP's P/E ratio is N/A. In terms of profitability, AAXT's ROE is +0.54%, compared to XCRP's ROE of -3.49%. Regarding short-term risk, AAXT and XCRP have similar daily volatility (0.00).Check XCRP's competition here
AAXT vs BMGP Comparison April 2026
AAXT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AAXT stands at 1.6K. In comparison, BMGP has a market cap of 1.3K. Regarding current trading prices, AAXT is priced at $0.00, while BMGP trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AAXT currently has a P/E ratio of N/A, whereas BMGP's P/E ratio is N/A. In terms of profitability, AAXT's ROE is +0.54%, compared to BMGP's ROE of -0.50%. Regarding short-term risk, AAXT and BMGP have similar daily volatility (0.00).Check BMGP's competition here
AAXT vs IMRSQ Comparison April 2026
AAXT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AAXT stands at 1.6K. In comparison, IMRSQ has a market cap of 626. Regarding current trading prices, AAXT is priced at $0.00, while IMRSQ trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AAXT currently has a P/E ratio of N/A, whereas IMRSQ's P/E ratio is N/A. In terms of profitability, AAXT's ROE is +0.54%, compared to IMRSQ's ROE of -1.30%. Regarding short-term risk, AAXT and IMRSQ have similar daily volatility (0.00).Check IMRSQ's competition here
AAXT vs STBV Comparison April 2026
AAXT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AAXT stands at 1.6K. In comparison, STBV has a market cap of 471. Regarding current trading prices, AAXT is priced at $0.00, while STBV trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AAXT currently has a P/E ratio of N/A, whereas STBV's P/E ratio is N/A. In terms of profitability, AAXT's ROE is +0.54%, compared to STBV's ROE of -1.13%. Regarding short-term risk, AAXT and STBV have similar daily volatility (0.00).Check STBV's competition here
AAXT vs OMDD Comparison April 2026
AAXT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AAXT stands at 1.6K. In comparison, OMDD has a market cap of 310. Regarding current trading prices, AAXT is priced at $0.00, while OMDD trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AAXT currently has a P/E ratio of N/A, whereas OMDD's P/E ratio is N/A. In terms of profitability, AAXT's ROE is +0.54%, compared to OMDD's ROE of N/A. Regarding short-term risk, AAXT and OMDD have similar daily volatility (0.00).Check OMDD's competition here
AAXT vs QMED Comparison April 2026
AAXT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AAXT stands at 1.6K. In comparison, QMED has a market cap of 17. Regarding current trading prices, AAXT is priced at $0.00, while QMED trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AAXT currently has a P/E ratio of N/A, whereas QMED's P/E ratio is -0.00. In terms of profitability, AAXT's ROE is +0.54%, compared to QMED's ROE of N/A. Regarding short-term risk, AAXT and QMED have similar daily volatility (0.00).Check QMED's competition here